Ignite Creation Date:
2024-05-06 @ 10:53 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03379727
Status:
COMPLETED
Last Update Posted:
2024-02-29
First Post:
2017-12-14
Brief Title:
Study to Assess the Safety and Efficacy of Midostaurin PKC412 in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 FLT3 Kinase Receptor-mutated Acute Myeloid Leukemia
Sponsor:
Organization:
Novartis